Micro-Arrayed Human Embryonic Stem Cells-Derived Cardiomyocytes for In Vitro Functional Assay

Introduction The heart is one of the least regenerative organs in the body and any major insult can result in a significant loss of heart cells. The development of an in vitro-based cardiac tissue could be of paramount importance for many aspects of the cardiology research. In this context, we developed an in vitro assay based on human cardiomyocytes (hCMs) and ad hoc micro-technologies, suitable for several applications: from pharmacological analysis to physio-phatological studies on transplantable hCMs. We focused on the development of an assay able to analyze not only hCMs viability, but also their functionality. Methods hCMs were cultured onto a poly-acrylamide hydrogel with tunable tissue-like mechanical properties and organized through micropatterning in a 20×20 array. Arrayed hCMs were characterized by immunofluorescence, GAP-FRAP analyses and live and dead assay. Their functionality was evaluated monitoring the excitation-contraction coupling. Results Micropatterned hCMs maintained the expression of the major cardiac markers (cTnT, cTnI, Cx43, Nkx2.5, α-actinin) and functional properties. The spontaneous contraction frequency was (0.83±0.2) Hz, while exogenous electrical stimulation lead to an increase up to 2 Hz. As proof of concept that our device can be used for screening the effects of pathological conditions, hCMs were exposed to increasing levels of H2O2. Remarkably, hCMs viability was not compromised with exposure to 0.1 mM H2O2, but hCMs contractility was dramatically suppressed. As proof of concept, we also developed a microfluidic platform to selectively treat areas of the cell array, in the perspective of performing multi-parametric assay. Conclusions Such system could be a useful tool for testing the effects of multiple conditions on an in vitro cell model representative of human heart physiology, thus potentially helping the processes of therapy and drug development.

[1]  Milica Radisic,et al.  Medium perfusion enables engineering of compact and contractile cardiac tissue. , 2004, American journal of physiology. Heart and circulatory physiology.

[2]  Masayuki Yamato,et al.  Cell sheet engineering for heart tissue repair. , 2008, Advanced drug delivery reviews.

[3]  Milica Radisic,et al.  Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Marina Flaibani,et al.  Electrophysiologic stimulation improves myogenic potential of muscle precursor cells grown in a 3D collagen scaffold , 2008, Neurological research.

[5]  N. Elvassore,et al.  Micropatterning topology on soft substrates affects myoblast proliferation and differentiation. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[6]  Shulamit Levenberg,et al.  Tissue Engineering of Vascularized Cardiac Muscle From Human Embryonic Stem Cells , 2007, Circulation research.

[7]  M. Nirmalan,et al.  The effects of hydrogen peroxide on intracellular calcium handling and contractility in the rat ventricular myocyte. , 2010, Cell calcium.

[8]  Christian Giaume,et al.  Connexin Methods and Protocols , 2010 .

[9]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.

[10]  Thomas Rau,et al.  Human Engineered Heart Tissue as a Versatile Tool in Basic Research and Preclinical Toxicology , 2011, PloS one.

[11]  Lisa E. Freed,et al.  Accordion-Like Honeycombs for Tissue Engineering of Cardiac Anisotropy , 2008, Nature materials.

[12]  P. Tam,et al.  Extrinsic regulation of pluripotent stem cells , 2010, Nature.

[13]  Andrew J deMello,et al.  Micro- and nanofluidic systems for high-throughput biological screening. , 2009, Drug discovery today.

[14]  Megan L. McCain,et al.  Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip. , 2011, Lab on a chip.

[15]  Elisa Cimetta,et al.  Soft substrates drive optimal differentiation of human healthy and dystrophic myotubes. , 2010, Integrative biology : quantitative biosciences from nano to macro.

[16]  Elisa Cimetta,et al.  Microfluidic-driven viral infection on cell cultures: Theoretical and experimental study. , 2012, Biomicrofluidics.

[17]  Y. Kakinuma,et al.  Engineered Heart Tissue: A Novel Tool to Study the Ischemic Changes of the Heart In Vitro , 2010, PloS one.

[18]  S. Cook,et al.  Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. , 1999, Circulation research.

[19]  Mark Slack,et al.  Impact of new technologies for cellular screening along the drug value chain. , 2010, Drug discovery today.

[20]  G. Lamb,et al.  Acute effects of reactive oxygen and nitrogen species on the contractile function of skeletal muscle , 2011, The Journal of physiology.

[21]  Teodor Veres,et al.  Cell culture chips for simultaneous application of topographical and electrical cues enhance phenotype of cardiomyocytes. , 2009, Lab on a chip.

[22]  Kumaraswamy Nanthakumar,et al.  Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue , 2009, Proceedings of the National Academy of Sciences.

[23]  D. Bers Cardiac excitation–contraction coupling , 2002, Nature.

[24]  Ali Khademhosseini,et al.  A cell-based biosensor for real-time detection of cardiotoxicity using lensfree imaging. , 2011, Lab on a chip.

[25]  Milica Radisic,et al.  Optical mapping of impulse propagation in engineered cardiac tissue. , 2009, Tissue engineering. Part A.

[26]  M. Vos,et al.  Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes. , 2010, Stem cell research.

[27]  C. Murry,et al.  Systems approaches to preventing transplanted cell death in cardiac repair. , 2008, Journal of molecular and cellular cardiology.

[28]  Jianjun Guan,et al.  Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy. , 2010, Advanced drug delivery reviews.

[29]  Lior Gepstein,et al.  A photopolymerizable hydrogel for 3-D culture of human embryonic stem cell-derived cardiomyocytes and rat neonatal cardiac cells. , 2009, Journal of molecular and cellular cardiology.

[30]  S. Schiaffino,et al.  Troponin I switching in the developing heart. , 1989, The Journal of biological chemistry.

[31]  David D. Shin,et al.  Review of current and investigational pharmacologic agents for acute heart failure syndromes. , 2007, The American journal of cardiology.

[32]  M. Bönstrup,et al.  Development of a Drug Screening Platform Based on Engineered Heart Tissue , 2010, Circulation research.

[33]  Charles E. Murry,et al.  Growth of Engineered Human Myocardium With Mechanical Loading and Vascular Coculture , 2011, Circulation research.

[34]  Robert Passier,et al.  Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. , 2010, Stem cell research.

[35]  Lior Gepstein,et al.  Human embryonic stem cells for cardiomyogenesis. , 2008, Journal of molecular and cellular cardiology.

[36]  Milica Radisic,et al.  Electrical stimulation systems for cardiac tissue engineering , 2009, Nature Protocols.

[37]  C. Mummery,et al.  Prospects for pluripotent stem cell‐derived cardiomyocytes in cardiac cell therapy and as disease models , 2009, Journal of cellular biochemistry.

[38]  Elisa Cimetta,et al.  Production of arrays of cardiac and skeletal muscle myofibers by micropatterning techniques on a soft substrate , 2009, Biomedical microdevices.

[39]  Milica Radisic,et al.  Interactive effects of surface topography and pulsatile electrical field stimulation on orientation and elongation of fibroblasts and cardiomyocytes. , 2007, Biomaterials.

[40]  Eric D. Adler,et al.  Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population , 2008, Nature.

[41]  C. Cannizzaro,et al.  Practical aspects of cardiac tissue engineering with electrical stimulation. , 2007, Methods in molecular medicine.

[42]  Adam J Engler,et al.  Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating , 2008, Journal of Cell Science.

[43]  J. Itskovitz‐Eldor,et al.  Functional Properties of Human Embryonic Stem Cell–Derived Cardiomyocytes: Intracellular Ca2+ Handling and the Role of Sarcoplasmic Reticulum in the Contraction , 2006, Stem cells.

[44]  T. Vanden Hoek,et al.  Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. , 1997, Journal of molecular and cellular cardiology.

[45]  S. Schiaffino,et al.  Troponin T switching in the developing rat heart. , 1988, The Journal of biological chemistry.

[46]  S. Sen,et al.  Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.